ESBC
E.S. Barr & Co Portfolio holdings
AUM
$1.74B
This Quarter Return
-6.36%
1 Year Return
+23.32%
3 Year Return
+75.37%
5 Year Return
+142.63%
10 Year Return
+238.12%
AUM
$1.13B
AUM Growth
+$1.13B
(-7.8%)
Cap. Flow
+$72M
Cap. Flow
% of AUM
6.37%
Top 10 Holdings %
Top 10 Hldgs %
56.13%
Holding
92
New
2
Increased
17
Reduced
48
Closed
6
Top Buys
| 1 |
Charter Communications
CHTR
|
$8.3M |
| 2 |
JPMorgan Chase
JPM
|
$1.45M |
| 3 |
Nike
NKE
|
$1.32M |
| 4 |
Cable One
CABO
|
$1.11M |
| 5 |
Diamond Hill
DHIL
|
$718K |
Top Sells
| 1 |
Wynn Resorts
WYNN
|
$5.25M |
| 2 |
Brookfield
BN
|
$2.87M |
| 3 |
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
|
$2.36M |
| 4 |
Take-Two Interactive
TTWO
|
$1.72M |
| 5 |
Booking.com
BKNG
|
$1.55M |
Sector Composition
| 1 | Financials | 56.66% |
| 2 | Communication Services | 13.4% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Consumer Staples | 5.23% |
| 5 | Technology | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
RTX Corp
RTX
$212B
| $319K | 0.03% |
3,894
| – | – |
|
77
Automatic Data Processing
ADP
$121B
| $308K | 0.03% |
1,360
| – | – |
|
78
US Bancorp
USB
$75.5B
| $294K | 0.03% |
7,300
| – | – |
|
79
Union Pacific
UNP
$132B
| $282K | 0.03% |
1,446
-59
| -4% | -$11.5K |
|
|
PSTX
80
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $270K | 0.02% |
76,398
| – | – |
|
81
Texas Pacific Land
TPL
$20.9B
| $267K | 0.02% |
150
| – | – |
|
82
Accenture
ACN
$158B
| $244K | 0.02% |
950
| – | – |
|
83
Caterpillar
CAT
$194B
| $220K | 0.02% |
1,338
-47
| -3% | -$7.73K |
|
84
Ford
F
$46.2B
| $187K | 0.02% |
+16,675
| New | +$187K |
|
85
Microvision
MVIS
$334M
| $94K | 0.01% |
26,000
| – | – |
|
|
PSTH
86
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| – | – |
-118,179
| Closed | -$2.36M |
|
87
Stock Yards Bancorp
SYBT
$2.34B
| – | – |
-11,687
| Closed | -$699K |
|
88
FedEx
FDX
$53.2B
| – | – |
-1,000
| Closed | -$227K |
|
89
Emerson Electric
EMR
$72.9B
| – | – |
-2,875
| Closed | -$229K |
|
90
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-3,317
| Closed | -$255K |
|
91
Altice USA
ATUS
$1.12B
| – | – |
-12,475
| Closed | -$115K |
|